Impacts of HER2-overexpression and molecular targeting therapy on the efficacy of stereotactic radiosurgery for brain metastases from breast cancer.
about
Is upfront stereotactic radiosurgery a rational treatment option for very elderly patients with brain metastases? A retrospective analysis of 106 consecutive patients age 80 years and olderThe Rationale for Targeted Therapies and Stereotactic Radiosurgery in the Treatment of Brain Metastases.Overall survival and the response to radiotherapy among molecular subtypes of breast cancer brain metastases treated with targeted therapies.Combined irradiation and targeted therapy or immune checkpoint blockade in brain metastases: toxicities and efficacy.Preliminary experience of the concurrent use of radiosurgery and T-DM1 for brain metastases in HER2-positive metastatic breast cancer.
P2860
Impacts of HER2-overexpression and molecular targeting therapy on the efficacy of stereotactic radiosurgery for brain metastases from breast cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Impacts of HER2-overexpression ...... metastases from breast cancer.
@en
Impacts of HER2-overexpression ...... metastases from breast cancer.
@nl
type
label
Impacts of HER2-overexpression ...... metastases from breast cancer.
@en
Impacts of HER2-overexpression ...... metastases from breast cancer.
@nl
prefLabel
Impacts of HER2-overexpression ...... metastases from breast cancer.
@en
Impacts of HER2-overexpression ...... metastases from breast cancer.
@nl
P2093
P2860
P1476
Impacts of HER2-overexpression ...... metastases from breast cancer.
@en
P2093
Motohiro Hayashi
Narisumi Cho
Shoji Yomo
P2860
P2888
P304
P356
10.1007/S11060-013-1046-1
P577
2013-01-08T00:00:00Z
P5875
P6179
1012296501